A culture of war and a culture of exile : Young eritreans in Germany and their relations to Eritrea : Figures et expériences diasporiques = Culture de guerre et culture d'exil. Les jeunes Erythréens d'Allemagne et leursrelations à l'Erythrée : Figures and diasporic experiencesCONRAD, Bettina.Revue européenne des migrations internationales. 2006, Vol 22, Num 1, pp 59-85, issn 0765-0752, 27 p.Article

German Adjuvant Intergroup Node-Positive Study: A Phase III Trial to Compare Oral Ibandronate Versus Observation in Patients With High-Risk Early Breast CancerVON MINCKWITZ, Gunter; MÖBUS, Volker; KREIENBERG, Rolf et al.Journal of clinical oncology. 2013, Vol 31, Num 28, pp 3531-3539, issn 0732-183X, 9 p.Article

Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer : A randomized trial (GABG-IV D-93)-The German adjuvant breast cancer groupKAUFMANN, Manfred; GRAF, Erika; SCHUMACHER, Martin et al.Journal of clinical oncology. 2005, Vol 23, Num 31, pp 7842-7848, issn 0732-183X, 7 p.Article

A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer : GABG-IV B-93KAUFMANN, Manfred; GRAF, Erika; VON MINCKWITZ, Gunter et al.European journal of cancer (1990). 2007, Vol 43, Num 16, pp 2351-2358, issn 0959-8049, 8 p.Article

CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients : A randomised trial (GABG trial IV-A-93)VON MINCKWITZ, Gunter; GRAF, Erika; KAUFMANN, Manfred et al.European journal of cancer (1990). 2006, Vol 42, Num 12, pp 1780-1788, issn 0959-8049, 9 p.Article

Effect of Luteinizing Hormone-Releasing Hormone Agonist on Ovarian Function After Modern Adjuvant Breast Cancer Chemotherapy: The GBG 37 ZORO StudyGERBER, Bernd; VON MINCKWITZ, Gunter; FEHM, Tanja et al.Journal of clinical oncology. 2011, Vol 29, Num 17, pp 2334-2341, issn 0732-183X, 8 p.Article

Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: Results of a randomised trial (GABG-IV E-93) - The German Adjuvant Breast Cancer GroupEIERMANN, Wolfgang; GRAF, Erika; KAUFMANN, Manfred et al.European journal of cancer (1990). 2010, Vol 46, Num 1, pp 84-94, issn 0959-8049, 11 p.Article